Zoetis Inc.

ZTS Biotech & pharma

Develops medicines and vaccines for animals.

Jun 2026Revenue $9.52B/yrExpenses $6.25B/yr
No trend
Figures by year

Is Zoetis profitable?

Yes. In the 12 months to Jun 2026, revenue was $9.52B and expenses $6.25B.

Fiscal year toRevenueExpensesPre-tax profit
Dec 2025$9.47B$6.11B$3.36B
Dec 2024$9.26B$6.12B$3.13B
Dec 2023$8.54B$5.61B$2.94B
Dec 2022$8.08B$5.42B$2.66B
Dec 2021$7.78B$5.29B$2.49B
Dec 2020$6.67B$4.68B$2.00B
Dec 2019$6.26B$4.46B$1.80B
Dec 2018$5.83B$4.13B$1.69B
Dec 2017$5.31B$3.78B$1.52B
Dec 2016$4.89B$3.66B$1.23B